Pharmaceuticals

Precision Oncology Market Forecast 2026–2035: How to Leverage Market Growth

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the precision oncology market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Precision Oncology Market show for the 2026–2030 period?

The precision oncology market has witnessed rapid growth in recent years. It is projected to increase from $106.21 billion in 2025 to $117.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to several factors, including the constrained availability of genomic sequencing technologies, the reliance on conventional chemotherapy, the rising global prevalence of cancer, the early embrace of immunotherapy, and the expanding research in molecular oncology.

The precision oncology market is poised for significant expansion in the coming years, projected to reach $175.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. Key drivers for this anticipated growth include the advancement of next-generation sequencing platforms, greater integration of bioinformatics and artificial intelligence (AI) in oncology, increased uptake of liquid biopsy and molecular imaging, the broadening of personalized treatment alternatives, and enhanced research partnerships between medical institutions and pharmaceutical firms. Prominent trends during this forecast period encompass the proliferation of targeted cancer therapies informed by molecular profiling, the wider acceptance of liquid biopsy and non-invasive diagnostic approaches, an increase in biomarker-based testing for tailored treatment strategies, the growing convergence of immunotherapy with genomic sequencing, and a heightened emphasis on addressing rare and challenging cancer types.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Drivers Are Shaping The Development Of The Precision Oncology Market?

The increasing awareness and shift towards personalized therapies are expected to propel the growth of the precision oncology market going forward. These personalized therapies are treatments customized to an individual’s genetic makeup, biomarkers, and specific disease characteristics to enhance effectiveness and reduce side effects. The increasing adoption of personalized therapies is due to advancements in genomic technologies that enable the precise identification of disease-driving mutations, allowing for more effective and targeted treatments. Precision oncology helps advance personalized therapies by using genomic and molecular profiling to tailor cancer treatment to the specific genetic makeup of a patient’s tumor. For instance, in February 2023, according to GOV.UK, a UK-based government department, the Health and Social Care Secretary signed an MoU with BioNTech SE to advance cancer vaccine research in England, aiming to deliver 10,000 personalized therapy doses to UK patients by 2030. Therefore, the increasing awareness and shift towards personalized therapies are driving the growth of the precision oncology market.

Which Segments Are Contributing To The Growth Of The Precision Oncology Market?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Which Trends Are Expected To Influence The Precision Oncology Market In The Upcoming Years?

Leading companies within the precision oncology market are concentrating on developing novel approaches, such as the molecular tumor board, to facilitate personalized treatment decisions by integrating genomic information with clinical context. A molecular tumor board refers to a specialized group of experts that examines and interprets complex genomic and molecular test data to guide precision-driven cancer therapies tailored to the specific tumor characteristics of individual patients. For example, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, introduced a precision oncology clinic as one of three personalized cancer care initiatives intended to revolutionize treatment through data-driven, genomic-focused strategies. This clinic provides customized cancer therapy based on each patient’s tumor genetic profile, enabling more accurate, effective treatments with fewer adverse effects. The method improves treatment outcomes, reduces toxicity, and enhances quality of life by aligning therapies with the unique molecular features of a patient’s cancer.

Who Are The Prominent Global Companies Shaping The Precision Oncology Market Landscape?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Precision Oncology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795